Halozyme Therapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2012
Total Assets: $134.7M
Liabilities Breakdown FY2012
Total Liabilities: $85.9M
Asset Breakdown
Total Assets: $134.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $99.5M | 73.9% |
| Accounts Receivable | $15.7M | 11.7% |
| Inventory | $2.7M | 2.0% |
| Property, Plant & Equipment | $3.7M | 2.7% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $13.2M | 9.8% |
Liabilities Breakdown
Total Liabilities: $85.9M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.3M | 2.6% |
| Long-Term Debt | $29.7M | 34.5% |
| Other Liabilities | $53.9M | 62.8% |